Show simple item record

dc.contributor.authorWorld Health Organizationen
dc.coverage.spatialGeneva
dc.date.accessioned2012-06-16T15:02:31Z
dc.date.available2012-06-16T15:02:31Z
dc.date.created2012en
dc.date.issued2012en
dc.identifier.isbn9789241209656
dc.identifier.isbn9789244209653 (‎Russian)‎
dc.identifier.issn0512-3054
dc.identifier.issn0250-8737 (‎Russian)‎
dc.identifier.urihttps://iris.who.int/handle/10665/44771
dc.descriptionxiv, 249 p.en
dc.language.isoenen
dc.language.isoru
dc.publisherWorld Health Organization
dc.publisherWorld Health Organization
dc.relation.ispartofseriesWHO technical report series ; 965en
dc.subject.meshDrug Information Servicesen
dc.subject.meshDrug Utilizationen
dc.subject.meshChilden
dc.subject.meshDrugs, Essential
dc.subject.otherPharmaceuticals and Biologicalsen
dc.titleThe selection and use of essential medicines : report of the WHO Expert Committee, March 2011 (‎including the 17th WHO model list of essential medicines and the 3rd WHO model list of essential medicines for children)‎en
dc.subject.meshqualifieradministration and dosageen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record